medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2005, Number 2

<< Back Next >>

Rev Invest Clin 2005; 57 (2)

Lung transplantation

Santillán-Doherty P, Jasso-Victoria R, Olmos-Zúñiga R, Sotres-Vega A, Argote-Greene LM, Escalante-Tattersfield T, Villalba-Caloca J

Language: Spanish
References: 45
Page: 350-357
PDF size: 70.20 Kb.


ABSTRACT

Lung transplantation (LT) has evolved to become an important alternative in the management of patients with end-stage pulmonary disease and chronic respiratory failure. The beginnings of this technique can be traced back to the experiments of Carrel and Guthrie over a hundred years ago. However, it was not until 1963 when the first clinical experience was performed by Hardy. Clinical success did not arrive until the 1980’s thanks to the works of the Toronto Lung Transplant Group. Well established criteria have been described in order to consider a patient as a potential candidate to receive a lung. Several diseases are capable of causing terminal lung damage and in general they can be classified according to their origin as obstructive (COPD, emphysema), restrictive (fibrosis), chronic infectious (cystic fibrosis, bronquiectasis), and vascular (primary pulmonary hypertension). The most frecuent diagnosis is COPD. Clynically relevant modes of LT include the implant of one lung (single LT), or both lungs (bilateral sequential LT). Transplantation of the cardiopulmonary block is reserved for special situations and lobar transplantation is still considered experimental. Donor condition is essential to the success of LT. The potential donor patient frecuently suffers deterioration in lung function due to edema formation or infection and both complications restrict lung’s using for transplantation. Lung preservation is also limited to a short period of time which rarely exceeds 6 hours in spite of specially-designed preservative solutions such as the low potassium dextran. Outcome after LT shows current one-year survival between 65-70% with reduction to 40-45% after five years. Mortality within the first year is usually related to primary graft failure and infection. Long-term survival depends on controlling infectious problems due to immunosupresion as well as the development of bronchilitis obliterans as a manifestation of chronic rejection. LT is a therapeutic modality reserved for selected patients with chronic respiratory failure due to end-stage lung disease.


REFERENCES

  1. Carrel A. The surgery of blood vessals. Bull Hopkins Hosp 1907; 18: 18-28.

  2. Hardy JD, Erasian S, Dalton ML. Autotransplantation and homotransplantation of the lung: Further studies. J Thorac Cardiovasc Surg 1963; 46: 606-15.

  3. Hardy JD, Webb WR, Dalton Ml, Walker GR. Lung homotransplantation in man. JAMA 1963; 12: 99-108.

  4. Magovern GJ, Yates AJ. Human homotransplantation of left lung: Report of a case. Ann NY Acad Sci 1964; 120: 710-28.

  5. White JJ. Tanser PH, Anthonisen NP, et al. Human lung homotransplantation. Can Med Assoc J 1966; 94: 1199-209.

  6. Veith F, Kamholz SL, Montefusco CM, et al. Lung transplantation 1983. Transplantation 1983; 35: 271-8.

  7. Wildevuur CR, Benfield JR. A review of 23 human lung transplantations by 20 surgeons. Ann Thorac Surg 1970; 9: 489-515.

  8. Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982; 306: 557-64.1

  9. Nelems JMW, Rebuck AS, Cooper JD, et al. Human lung transplantation. Chest 1980; 78: 569-73.

  10. Goldberg M, Lima O, Morgan E, et al. A comparison between cyclosporin A and methylprednisolone plus azathioprine on bronchial healing following canine lung autotransplantation. J Thorac Cardiovasc Surg 1983; 85: 824-6.

  11. Morgan E, Lima O, Goldberg M, et al. Successful revascularization of totally ischemic bronchial autografts with omental pedicle flaps in dogs. J Thorac Cardiovasc Surg 1982; 84: 204-10.

  12. Santillán-Doherty P, Jasso R, Gaxiola M, et al. Protección de la anastomosis bronquial con colgajo de omento en el trasplante pulmonar unilateral. Rev Invest Clin (Mex) 1989; 41: 117-22.

  13. Toronto lung transplant group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986; 314: 1140-5.

  14. Santillán-Doherty P. Trasplante unilateral de pulmón en un caso de fibrosis pulmonar terminal. Rev Invest Clin (Mex) 1990; 42: 127-34.

  15. The Toronto Lung Transplant Group. Experience with single lung transplantation for pulmonary fibrosis. JAMA 1988; 259: 2258-62.

  16. Mal H, Andreassin B, Pamela F, et al. Unilateral lung transplantation in end-stage pulmonary emphysema. Am Rev Resp Dis 1989; 140: 797-802.

  17. Low DE, Trulock EP, Kaiser LR, et al. Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema. J Thorac Cardiovasc Surg 1992; 103: 1119-26.

  18. Levine SM, Gibbons WJ, Bryan CL, et al. Single lung transplantation for primary pulmonary hypertension. Chest 1990; 98: 1107-15.

  19. Starnes VA, Stinson EB, Oyer PE, et al. Single lung transplantation: A new therapeutic option for patients with pulmonary hypertension. Transplant Proc 1991; 23: 1209-10.

  20. Spray TL, Mallory GB, Canter CE, et al. Pediatric lung transplantation for pulmonary hypertension and congenital heart disease. Ann Thorac Surg 1992; 54: 216-25.

  21. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung tranplant candidates. Tranplantation 1998; 66: 951-6.

  22. Yu AD, Garrity ER. Recipient selection. Chest Surg Clin N Am 2003; 13: 405-28.

  23. Santillán-Doherty P. El donador pulmonar: Cómo cuidar un pulmón sano. Neumol Cir Torax (Mex) 1991; 50: 4-6.

  24. Orens JB, Boehler A, de Perrot M, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003; 22: 1183-99.

  25. Santillán-Doherty P, Diliz H, Jasso R, et al. Lung procurement in Mexico. Transplant Proc 1993; 25: 3139-40.

  26. Cooper JD, Pearson FG, Patterson GA, et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg 1987; 93: 172-81.

  27. Calhoon JH, Grover FL, Gibbons WJ, et al. Single lung transplantation: Alternative, indications and technique. J Thorac Cardiovasc Surg 1991; 101: 816-25.

  28. Baile EM, Jasso-Victoria R, Sotres-Vega A, et al. Tracheobronchial blood flow after a modified canine lung autotransplant: Effect of omental wrapping. Transplant Proc 1992; 24: 2024-9.

  29. Patterson GA, Cooper JD, Kaiser LR, et al. Improved technique for heart-lung transplantation. J Thorac Cardiovasc Surg 1984; 87: 930-5.

  30. Pasque MK, Cooper JD, Kaiser LR, et al. Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg 1990; 49: 785-91.

  31. Bisson A, Bonnette P. A new technique for double lung transplantation: Bilateral single lung transplantation. J Thorac Cardiovasc Surg 1992; 103: 40-6.

  32. Lau CL, Patterson A. Technical considerations in lung transplantation. Chest Surg Clin N Am 2003; 13: 463-83.

  33. Jamieson SW, Stinson EB, Oyer PE, et al. Operative technique for heart-lung transplantation. J Thorac Cardiovasc Surg 1984; 87: 930-5.

  34. Bowdish ME, Barr ML, Starnes VA. Living lobar transplantation. Chest Surg Clin N Am 2003; 13: 505-24.

  35. Todd TR, Goldberg M, Koshal A, et al. Separate extraction of cardiac and pulmonary grafts from a single organ donor. Ann Thorac Surg 1988; 46: 356-9.

  36. Kaiser LR, Cooper JD. The current status of lung transplantation. Adv Surg 1992; 25: 259-307.

  37. de Perrot M, Keshavjee S. Lung preservation. Chest Surg Clin N Am 2003; 13: 443-62.

  38. Levine SM. A survey of clinical practice of lung transplantation in North America. Chest 2004; 125(4): 1224-38.

  39. Chakinala MM, Trulock EP. Acute allograft rejection after lung transplantation: Diagnosis and therapy. Chest Surg Clin N Am 2003; 13: 525-42.

  40. Santillán-Doherty P, Odor-Morales A, Jasso R, et al. Urinary thromboxane B2 as an indicator of acute rejection in lung allotransplantation. Transplantation 1988; 45: 852-6.

  41. Santillán-Doherty P, Odor-Morales A, Jasso R, et al. Thromboxane B2 and lung transplantation: Correlation of rejection with levels detected in bronchoalveolar lavage. Transplan Proc 1989; 21: 3650-2.

  42. Santillán-Doherty P, Jasso-Victoria R, Sotres-Vega A, et al. Urinary thromboxane B2 excretion during acute rejection in cyclosporine treated experimental lung allotransplantation. Transplant Proc 1992; 24: 2022-3.

  43. Santillán-Doherty P, Jasso-Victoria R, Sotres-Vega A, et al. Pulmonary perfusion during lung transplant rejection and experimental pneumonia. Transplantation 1992; 53: 533-5.

  44. Trulock EP, Edwards LB, Taylor DO, Bouceck MM, Mohacsi PJ, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twentieth official report-2003. J Heart Lung Transplant 2003; 22: 625-35.

  45. Bouceck MM, Edwards LB, Taylor DO, Keck BM, Trulock EP, Mohacsi PJ, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Sixth official pediatric report-2003. J Heart Lung Transplant 2003; 22: 636-52.




2020     |     www.medigraphic.com